These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 17611378)
1. [Surgery and chemotherapy for colorectal cancer: current status and perspective]. Kawamura Y; Konishi F Nihon Shokakibyo Gakkai Zasshi; 2007 Jul; 104(7):1018-24. PubMed ID: 17611378 [No Abstract] [Full Text] [Related]
2. Metastatic colorectal cancer: is surgery necessary? Schmidt C J Natl Cancer Inst; 2009 Aug; 101(16):1113-5. PubMed ID: 19671774 [No Abstract] [Full Text] [Related]
3. Turning point for colorectal cancer clinical trials. Meropol NJ J Clin Oncol; 2006 Jul; 24(21):3322-4. PubMed ID: 16849744 [No Abstract] [Full Text] [Related]
4. Current status of adjuvant therapy for colorectal cancer. O'Connell MJ Oncology (Williston Park); 2004 May; 18(6):751-5; discussion 755-8. PubMed ID: 15214594 [TBL] [Abstract][Full Text] [Related]
5. [5-fluorouracil and leucovorin therapy for advanced colorectal cancer]. Shimoyama S; Kondo K; Kataoka M Nihon Rinsho; 2003 Sep; 61 Suppl 7():356-9. PubMed ID: 14574912 [No Abstract] [Full Text] [Related]
6. [Progress of chemotherapy in colorectal cancer]. Komatsu Y Gan To Kagaku Ryoho; 2007 Nov; 34(11):1771-6. PubMed ID: 18064761 [No Abstract] [Full Text] [Related]
7. [IFL]. Yamazaki K; Yoshino T; Boku N Gan To Kagaku Ryoho; 2006 Jul; 33(7):907-10. PubMed ID: 16835478 [TBL] [Abstract][Full Text] [Related]
8. Recommendation for irinotecan, 5-fluorouracil, and leucovorin as first-line therapy for colorectal cancer. Fisher MD Clin Colorectal Cancer; 2001 Aug; 1(2):82-4. PubMed ID: 12445364 [No Abstract] [Full Text] [Related]
9. Multiagent regimens for metastatic colorectal cancer: if some is good, more must be better. Allegra C; George T; Yothers G J Natl Cancer Inst; 2011 Jan; 103(1):4-5. PubMed ID: 21123834 [No Abstract] [Full Text] [Related]
10. N9741: a phase III study comparing irinotecan to oxaliplatin-containing regimens in advanced colorectal cancer. Goldberg RM Clin Colorectal Cancer; 2002 Aug; 2(2):81. PubMed ID: 12453321 [No Abstract] [Full Text] [Related]
11. Colorectal cancer: to stack or sequence therapy? Azvolinsky A J Natl Cancer Inst; 2015 May; 107(5):. PubMed ID: 25957442 [No Abstract] [Full Text] [Related]
12. Irinotecan/5-FU/leucovorin, oxaliplatin/5-FU/leucovorin, and oxaliplatin/irinotecan are each effective in the treatment of 5-FU-resistant advanced colorectal cancer. Fisher MD Clin Colorectal Cancer; 2001 Aug; 1(2):85-6. PubMed ID: 12445365 [No Abstract] [Full Text] [Related]
13. [Cost effectiveness analysis of two adjuvant regimens in the treatment of colorectal cancer: an interpretation of the MOSAIC Study]. Rebesco B; Cantagalli E; Amalfitano ME Tumori; 2005; 91(6):suppl 1-10. PubMed ID: 16457161 [No Abstract] [Full Text] [Related]
14. Always look at the bright side of drugs? Nygren P Acta Oncol; 2015 Feb; 54(2):145-7. PubMed ID: 25608927 [No Abstract] [Full Text] [Related]
15. Evolution of systemic therapy for metastatic colorectal cancer. Geh JI; Ma YT Colorectal Dis; 2011 Aug; 13(8):852-4. PubMed ID: 21762349 [No Abstract] [Full Text] [Related]